RENALYTIX PLC – Aim Rule 17 Disclosure
RNS Number : 9309R Renalytix PLC 24 August 2026 Renalytix plc (“Renalytix” or the “Company“) AIM Rule
RNS Number : 9309R Renalytix PLC 24 August 2026 Renalytix plc (“Renalytix” or the “Company“) AIM Rule
RNS Number : 2622K Renalytix PLC 30 June 2026 Renalytix plc (“Renalytix” or the “Company“) Real world
Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces its unaudited interim results for the six months ended 31 December 2019, a period of considerable progress in advancing the processes of regulatory and reimbursement approval and preparing for commercialisation.